Citadel Advisors - VOLITIONRX LTD ownership

VOLITIONRX LTD's ticker is VNRX and the CUSIP is 928661107. A total of 31 filers reported holding VOLITIONRX LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of VOLITIONRX LTD
ValueSharesWeighting
Q2 2023$39,222
-65.2%
28,217
-52.2%
0.00%
Q1 2023$112,724
-62.5%
59,018
-52.3%
0.00%
Q4 2022$300,725
+55.0%
123,755
-13.5%
0.00%
Q3 2022$194,000
+43.7%
143,077
+116.9%
0.00%
Q2 2022$135,000
-25.8%
65,976
+9.3%
0.00%
Q1 2022$182,000
+2.8%
60,338
+6.5%
0.00%
Q4 2021$177,000
+3.5%
56,638
+2.5%
0.00%
Q3 2021$171,000
+185.0%
55,275
+205.4%
0.00%
Q2 2021$60,000
+20.0%
18,100
+40.6%
0.00%
Q2 2020$50,00012,8750.00%
Other shareholders
VOLITIONRX LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Lagoda Investment Management, L.P. 1,817,654$10,215,00012.02%
GARRISON BRADFORD & ASSOCIATES INC 15,500$87,0000.12%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 224,400$1,261,0000.02%
Hartford Financial Management Inc. 8,300$47,0000.02%
Virtu Financial LLC 20,125$113,0000.01%
Larson Financial Group LLC 2,350$13,0000.01%
A.R.T. Advisors, LLC 16,137$91,0000.01%
BREWIN DOLPHIN LTD 6,575$36,9520.00%
OPPENHEIMER & CO INC 12,760$72,0000.00%
TRUEWEALTH LLC 800$4,0000.00%
View complete list of VOLITIONRX LTD shareholders